Tag: biomedical
-
FDA Approves Sickle Cell Drug
The Food and Drug Administration today approved a new drug that reduces the tendency for blood cells in people with sickle cell disease to stick together and block blood vessels.
-
Device Shown to Reduce Migraine Occurrence
A clinical trial shows an electronic device worn with headphones reduces the number of days with migraines among people with a history of their occurrence.
-
Little Health Impact Found from Engineered Mosquitoes
An assessment by Dutch health authorities concludes mosquitoes genetically engineered to produce offspring that die before adulthood pose few health or environmental risks to humans.
-
Feasibility, Safety Shown for Personal Tumor Vaccine
A pilot study among individuals with a form of skin cancer shows a vaccine aiming at proteins specific to a person’s tumor is safe and can generate a complex immune response attacking the tumor.
-
Game App Improves Memory Among Cognitive Impaired
A brain training game for an iPad was shown in a clinical study to improve the memory of people with mild cognitive impairment, a precursor stage to dementia.
-
Chip Device Quickly Detects Sepsis in Blood
An engineering team designed a lab-on-a-chip device that in tests with hospital patients shows it can find signs of sepsis in a drop of blood in about 30 minutes.
-
Glaxo Using Artificial Intelligence for Drug Discovery
Drug maker GlaxoSmithKline is hiring a company that applies artificial intelligence for drug discovery and design to identify new small-molecule compounds for up to 10 disease targets.
-
Nerve Stimulation Approved for Children’s Epilepsy
The U.S. Food and Drug Administration approved use of vagus nerve stimulation to treat epilepsy in children who do not respond to drug therapy as young as 4 years old.
-
NIH Funds Nanotech Tools for Cancer, Blood Clots
A bioengineering lab is receiving awards from National Institutes of Health to apply nanotechnology to treatments for breast cancer and diagnostics for deep vein blood clots.
-
Second Trial Approved for Cancer Pain Drug
The U.S. Food and Drug Administration approved a new clinical trial to test the efficacy and safety of an experimental drug designed to relieve stubborn chronic pain associated with cancer.